Mr. Densel joined the company this year as president of U.S. operations. He succeeds Guy Neev as CEO of Check-Cap.
Mr. Densel has held leadership positions at companies including Boston Scientific, Genzyme Biosurgery and Hologic.
“As we prepare to execute on near and long-term corporate and clinical milestones, including a CE mark application and the commencement of an FDA pivotal study next year, our board of directors and management team believes that Bill’s experience and track record will enable us to effectively and efficiently realize our clinical, regulatory and reimbursement goals,” said Tomer Kariv, Check-Cap’s board chairman.
More articles on gastroenterology:
5 GI physicians in the news – Aug. 7, 2015
New study supports use of Stretta for GERD treatment
What do gastroenterologists do to relax?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
